These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11930693)

  • 21. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
    Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M
    Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neferine Enhances the Antitumor Effect of Mitomycin-C in Hela Cells Through the Activation of p38-MAPK Pathway.
    Eid W; Abdel-Rehim W
    J Cell Biochem; 2017 Oct; 118(10):3472-3479. PubMed ID: 28328092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the Mdr1a P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in mice.
    Desrayaud S; De Lange EC; Lemaire M; Bruelisauer A; De Boer AG; Breimer DD
    J Pharmacol Exp Ther; 1998 May; 285(2):438-43. PubMed ID: 9580581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of mitomycin C on radiation-induced cell death in human cervical squamous cell carcinomas.
    Tanaka T; Umesaki N
    Eur J Gynaecol Oncol; 2005; 26(4):411-4. PubMed ID: 16122190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
    Zhao GZ; Tan WL; Zheng SB; Wu YD; Xie Y; Zhu WH
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1623-5, 1628. PubMed ID: 17121717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The reversal of multidrug resistance in multicellular tumor spheroids by SDZ PSC 833.
    Ehrlich PH; Moustafa ZA; Archinal-Mattheis AE; Newman MJ; Bair KW; Cohen D
    Anticancer Res; 1997; 17(1A):129-33. PubMed ID: 9066642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of human multidrug-resistant neoplastic cell lines to paclitaxel-induced-radiosensitization is reduced by the non-immunosuppressive cyclosporine analog SDZ PSC 833.
    Sedlak J; Hunakova L; Chorvath M; Sulikova M; Novotny L; Boljesikova E; Zeillinger R; Chorvath B
    Anticancer Res; 1998; 18(4C):3099-105. PubMed ID: 9713517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA; Kang Y; Greaves B; Perry RR
    J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations.
    Willson JK; Long BH; Marks ME; Brattain DE; Wiley JE; Brattain MG
    Cancer Res; 1984 Dec; 44(12 Pt 1):5880-5. PubMed ID: 6437674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosiglitazone reverses mitomycin C resistance in human gastric cancer cells.
    Zhang L; Hu JF; Li GQ; Xiao X; Su Q
    Am J Med Sci; 2012 May; 343(5):382-7. PubMed ID: 22052411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
    Qu QL; Zhang YG; Yang LZ; Sun L
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells.
    Cabot MC; Giuliano AE; Han TY; Liu YY
    Cancer Res; 1999 Feb; 59(4):880-5. PubMed ID: 10029079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Scalamogna D; Xia H; O'Toole S; Roy D; Emerson EO; Gupta V; Zaren HA
    Int J Cancer; 1996 Mar; 65(6):852-7. PubMed ID: 8631603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia.
    Takeuchi H; Baba H; Maehara Y; Sugimachi K; Newman RA
    Cancer Chemother Pharmacol; 1996; 38(1):1-8. PubMed ID: 8603441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A diffusible resistance factor(s) in spontaneous mitomycin resistant mammalian cancer cells.
    Wan ZG; Kobayashi H; Hayakawa A; Ishigaki T
    Nagoya J Med Sci; 1998 May; 61(1-2):37-45. PubMed ID: 9664765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human tumor xenograft growth in nude mice by a conjugate of monoclonal antibody LA22 to epidermal growth factor receptor with anti-tumor antibiotics mitomycin C.
    Shao W; Zhao S; Liu Z; Zhang J; Ma S; Sato JD; Zhang P; Tong M; Han J; Wang Y; Bai D; Wang F; Sun L
    Biochem Biophys Res Commun; 2006 Oct; 349(2):816-24. PubMed ID: 16950201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the nonimmunosuppressive cyclosporin analog SDZ PSC-833 on colchicine and doxorubicin biliary secretion by the rat in vivo.
    Speeg KV; Maldonado AL
    Cancer Chemother Pharmacol; 1994; 34(2):133-6. PubMed ID: 7910787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of PSC 833 on the efficacy of doxorubicin in vitro in a medullary thyroid carcinoma cell line.
    Massart C; Gibassier J; Denais A; Genetet N
    Anticancer Res; 1998; 18(4C):2953-6. PubMed ID: 9713490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term ethanol exposure causes human liver cancer cells to become resistant to mitomycin C treatment through the inactivation of bad-mediated apoptosis.
    Huang CS; Lee YR; Chen CS; Tu SH; Wang YJ; Lee CH; Chen LC; Chang HW; Chang CH; Chih-Ming S; Wu CH; Ho YS
    Mol Carcinog; 2010 Aug; 49(8):728-38. PubMed ID: 20623640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.